Severe Acquired Coagulopathy During Fulminant Staphylococcus aureus Sepsis Most Likely Caused by S. aureus Exotoxins (SSLs)

  • Lonneke Draaijers Rijnstate Arnhem
  • Robert-Jan Hassing Internal Medicine, Infectious Diseases, Rijnstate Hospital Arnhem, The Netherlands
  • Menno Kooistra Internal Medicine, Nephrology, Rijnstate Hospital Arnhem, The Netherlands
  • KoK van Kessel Medical Microbiology, University Medical Center Utrecht, The Netherlands
  • Marcel Hovens Internal Medicine, Vascular Medicine, Rijnstate Hospital Arnhem, The Netherlands
DOI: https://doi.org/10.12890/2018_001002

Keywords

Staphylococcus aureus, coagulopathy, staphylococcal superantigen-like protein, coagulation factor Xa, disseminated intravascular coagulation

Abstract

Haemostatic abnormalities frequently occur during sepsis and are most often attributed to disseminated intravascular coagulation (DIC). We report the case of a patient with severe coagulopathy acquired during fulminant S. aureus sepsis. DIC was not present. This coagulopathy was most likely caused by S. aureus exotoxins forming inhibitory complexes with coagulation factor Xa.

References

  • Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis 2010;2:e2010024.

  • Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible staphylococcus aureus. Infection control and hospital epidemiology. Infect Control Hosp Epidemiol 2007;28:273–279.

  • Itoh S, Yokoyama R, Kamoshida G, Fujiwara T, Okada H, Takii T, et al. Staphylococcal superantigen-like protein 10 (SSL10) inhibits blood coagulation by binding to prothrombin and factor Xa via their gamma-carboxyglutamic acid (Gla) domain. J Biol Chem 2013;288:21569–21580.

  • Samama MM, Contant G, Spiro TE, Perzborn E, Le Flem L, Guinet C, et al. Laboratory assessment of rivaroxaban: a review. Thromb J 2013;11:11.

  • Yokoyama R, Itoh S, Kamoshida G, Takii T, Fujii S, Tsuji T, et al. Staphylococcal superantigen-like protein 3 binds to the Toll-like receptor 2 extracellular domain and inhibits cytokine production induced by staphylococcus aureus, cell wall component, or lipopeptides in murine macrophages. Infect Immun 2012;80:2816–2825.

  • Bardoel BW, Vos R, Bouman T, Aerts PC, Bestebroer J, Huizinga EG, et al. Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3. J Mol Med (Berl) 2012;90:1109–1120.

  • Walenkamp AM, Boer IG, Bestebroer J, Rozeveld D, Timmer-Bosscha H, Hemrika W, et al. Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration. Neoplasia 2009;11:333–344.

  • Itoh S, Hamada E, Kamoshida G, Yokoyama R, Takii T, Onozaki K, et al. Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway. Mol Immunol 2010;47:932–938.

  • Patel D, Wines BD, Langley RJ, Fraser JD. Specificity of staphylococcal superantigen-like protein 10 toward the human IgG1 Fc domain. J Immunol 2010;184:6283–6292.

  • den Reijer PM, Lemmens-den Toom N, Kant S, Snijders SV, Boelens H, Tavakol M, et al. Characterization of the humoral immune response during staphylococcus aureus bacteremia and global gene expression by staphylococcus aureus in human blood. PLoS One 2013;8:e53391.

    • Published: 2018-12-27

    Issue: Vol 5 No 12 (view)

    Section: Articles

    How to cite:
    Draaijers, L., Hassing, R.-J., Kooistra, M., van Kessel, K., & Hovens, M. (2018). Severe Acquired Coagulopathy During Fulminant Staphylococcus aureus Sepsis Most Likely Caused by S. aureus Exotoxins (SSLs). European Journal of Case Reports in Internal Medicine, 5(12). https://doi.org/https://doi.org/10.12890/2018_001002